(Q42403308)

29 October 2017

L-BLP25 vaccine plus letrozole for breast cancer: Is translation possible? (English)

1 reference

29 October 2017

Michael Degregorio

1

1 reference

29 October 2017

Michael Degregorio

2

1 reference

29 October 2017

Gregory T Wurz

3

1 reference

29 October 2017

Gregory T Wurz

4

1 reference

29 October 2017

Audrey Gutierrez

5

1 reference

29 October 2017

Audrey Gutierrez

6

1 reference

29 October 2017

Michael Wolf

7

1 reference

29 October 2017

1 November 2012

1 reference

29 October 2017

1 reference

29 October 2017

1

1 reference

29 October 2017

8

1 reference

29 October 2017

1422-1424

1 reference

CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients

29 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518524

L-BLP25 vaccine plus letrozole induces a TH1 immune response and has additive antitumor activity in MUC1-expressing mammary tumors in mice

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518524

Therapeutic cancer vaccines: current status and moving forward

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518524

The effects of tamoxifen on immunity.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518524

The cytoplasmic tail of MUC1: a very busy place

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518524

Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518524

Cisplatin treatment renders tumor cells more susceptible to attack by lymphokine-activated killer cells

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518524

The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518524

Immoderate inhibition of estrogen by anastrozole enhances the severity of experimental polyarthritis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518524

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518524

16 August 2018

Identifiers

DOI

10.4161/ONCI.21129

1 reference

29 October 2017

1 reference

29 October 2017

PubMed publication ID

23243615

1 reference